Gemcitabine-O-Si(di-iso)-O-Mc

Gemcitabine-O-Si(di-iso)-O-Mc Catalog number: BADC-00872

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Gemcitabine-O-Si(di-iso)-O-Mc is a drug-linker conjugate for ADC with potent antitumor activity by using Gemcitabine (a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent; HY-17026), linked via the ADC linker.

Category
ADCs Cytotoxin with Linkers
Product Name
Gemcitabine-O-Si(di-iso)-O-Mc
Catalog Number
BADC-00872
Molecular Formula
C24H36F2N4O7Si
Molecular Weight
558.65
Purity
>98%

Ordering Information

Catalog Number Size Price Quantity
BADC-00872 -- $-- Inquiry
Description
Gemcitabine-O-Si(di-iso)-O-Mc is a drug-linker conjugate for ADC with potent antitumor activity by using Gemcitabine (a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent; HY-17026), linked via the ADC linker.
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Gemcitabine-O-Si(di-iso)-O-Mc is a synthetic derivative of the antineoplastic agent gemcitabine, meticulously crafted to elevate its efficacy and delivery. Here are four key applications of this innovative compound:

Chemotherapy: Gemcitabine-O-Si(di-iso)-O-Mc plays a pivotal role in chemotherapy regimens targeting a spectrum of cancers like pancreatic, lung, and breast cancer. Its advanced delivery system ensures optimized drug concentrations reach malignant cells, amplifying therapeutic effectiveness. This tailored approach not only fosters superior treatment outcomes but also holds the promise of mitigating adverse effects linked to conventional gemcitabine therapy.

Targeted Drug Delivery: By transforming gemcitabine into Gemcitabine-O-Si(di-iso)-O-Mc, researchers unlock the potential for tailored drug delivery systems. These systems precisely guide the drug to cancerous cells, minimizing harm to healthy tissues. Such targeted precision not only augments therapeutic efficacy but also diminishes systemic toxicity.

Drug Combination Studies: Exploration of Gemcitabine-O-Si(di-iso)-O-Mc in synergy with other chemotherapeutic agents unveils the potential for enhanced anticancer effects. Combining this derivative with complementary drugs may synergistically elevate overall efficacy and surmount resistance mechanisms.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: Gemcitabine-O-Si(di-iso)-O-Mc
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket